BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 2, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 23, 1994
View Archived Issues
XOMA DISCONTINUES DEVELOPMENT OF CD5 PLUS
Read More
GLYCOMED'S PHASE II/III RESULTS OF GALARDIN ARE POSITIVE
Read More
AMGEN'S NEUPOGEN APPROVED FOR SEVERE CHRONIC NEUTROPENIA
Read More
SCHERER `DEMANDS' ACCESS TO PROCYTE'S SHAREHOLDER LIST
Read More
PTO TELLS ITS EXAMINERS TO ACCEPT `CREDIBLE' CLAIMS
Read More
PHARMACOPEIA SIGNS POTENTIAL $75M DEAL WITH SCHERING-PLOUGH
Read More
CENTOCOR GIVES BIOTECH A BOOST WITH FDA APPROVAL OF REOPRO
Read More
